Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone for CIC in Mexico
NCT02729909Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2016
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic idiopathic constipation (CIC) comparing Lubiprostone 24 μg with Placebo (2 arms). Primary endpoint: Spontaneous Bowel Movement Frequency at Week 1. Started May 2016; status: completed.
02
Drugs
lubiprostone
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT02729909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02729909.